Biora Therapeutics, Inc. Interest Expense
Biora Therapeutics, Inc. reported Interest Expense of $2.02 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Expense Statement
us-gaap:InterestExpense · last filed 2024-11-14
- Biora Therapeutics, Inc. interest expense for the quarter ending 2024-09-30 was $2.02M, a 22.22% decline year-over-year.
- Biora Therapeutics, Inc. interest expense for the quarter ending 2024-06-30 was $711.00K, a 73.70% decline year-over-year.
- Biora Therapeutics, Inc. interest expense for the quarter ending 2024-03-31 was $2.76M, a 2.87% increase year-over-year.
- Biora Therapeutics, Inc. interest expense for the quarter ending 2023-12-31 was $1.84M, a 31.47% decline year-over-year.
- Biora Therapeutics, Inc. interest expense for fiscal 2023 was $9.81M, a 10.69% decline from fiscal 2022.
- Biora Therapeutics, Inc. interest expense for fiscal 2022 was $10.99M, a 13.03% decline from fiscal 2021.
- Biora Therapeutics, Inc. interest expense for fiscal 2021 was $12.64M, a 27.44% increase from fiscal 2020.
- Biora Therapeutics, Inc. interest expense for fiscal 2020 was $9.91M, a 7.78% increase from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | $2.02M 10-Q · filed 2024-11-14 | $2.73M derived: sum of 2 quarters · filed 2024-11-14 | $5.48M 10-Q · filed 2024-11-14 | $7.32M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2024-06-30 | $711.00K 10-Q · filed 2024-08-12 | $3.47M 10-Q · filed 2024-08-12 | $5.31M derived: sum of 3 quarters · filed 2024-08-12 | $7.90M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2024-03-31 | $2.76M 10-Q · filed 2024-05-15 | $4.60M derived: sum of 2 quarters · filed 2024-05-15 | $7.19M derived: sum of 3 quarters · filed 2024-11-14 | $9.89M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-12-31 | $1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $4.43M derived: sum of 2 quarters · filed 2024-11-14 | $7.13M derived: sum of 3 quarters · filed 2024-11-14 | $9.81M 10-K · filed 2024-04-01 | ||||
| 2023-09-30 | $2.59M 10-Q · filed 2024-11-14 | $5.29M derived: sum of 2 quarters · filed 2024-11-14 | $7.97M 10-Q · filed 2024-11-14 | $10.66M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $2.70M 10-Q · filed 2024-08-12 | $5.38M 10-Q · filed 2024-08-12 | $8.07M derived: sum of 3 quarters · filed 2024-08-12 | $10.84M derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | $2.68M 10-Q · filed 2024-05-15 | $5.37M derived: sum of 2 quarters · filed 2024-05-15 | $8.14M derived: sum of 3 quarters · filed 2024-05-15 | $10.91M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $2.69M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $5.46M derived: sum of 2 quarters · filed 2024-04-01 | $8.23M derived: sum of 3 quarters · filed 2024-04-01 | $10.99M 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | $2.77M 10-Q · filed 2023-11-13 | $5.54M derived: sum of 2 quarters · filed 2023-11-13 | $8.30M 10-Q · filed 2023-11-13 | $10.49M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $2.77M 10-Q · filed 2023-08-14 | $5.53M 10-Q · filed 2023-08-14 | $7.72M derived: sum of 3 quarters · filed 2023-08-14 | $11.18M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $2.76M 10-Q · filed 2023-05-15 | $4.95M derived: sum of 2 quarters · filed 2023-05-15 | $8.40M derived: sum of 3 quarters · filed 2023-05-15 | $11.91M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $2.19M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $5.64M derived: sum of 2 quarters · filed 2023-03-30 | $9.15M derived: sum of 3 quarters · filed 2023-03-30 | $12.64M 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | $3.46M 10-Q · filed 2022-11-14 | $6.96M derived: sum of 2 quarters · filed 2022-11-14 | $10.45M 10-Q · filed 2022-11-14 | $13.17M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $3.50M 10-Q · filed 2022-08-15 | $7.02M 10-Q · filed 2022-08-15 | $9.71M derived: sum of 3 quarters · filed 2022-08-15 | $12.17M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $3.52M 10-Q · filed 2022-05-10 | $6.21M derived: sum of 2 quarters · filed 2022-05-10 | $8.66M derived: sum of 3 quarters · filed 2022-05-10 | $11.15M derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | $2.69M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $5.14M derived: sum of 2 quarters · filed 2022-03-28 | $7.63M derived: sum of 3 quarters · filed 2022-03-28 | $9.91M 10-K · filed 2022-03-28 | $9.98M 10-K · filed 2021-03-18 | |||
| 2020-09-30 | $2.46M 10-Q · filed 2021-11-10 | $2.48M 10-Q · filed 2020-11-09 | $4.95M derived: sum of 2 quarters · filed 2021-11-10 | $7.23M 10-Q · filed 2021-11-10 | $7.29M 10-Q · filed 2020-11-09 | $9.57M derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | $2.49M 10-Q · filed 2021-08-12 | $2.51M 10-Q · filed 2020-08-14 | $4.77M 10-Q · filed 2021-08-12 | $4.81M 10-Q · filed 2020-08-14 | $7.12M derived: sum of 3 quarters · filed 2021-08-12 | $9.44M derived: sum of 4 quarters · filed 2021-08-12 | ||
| 2020-03-31 | $2.30M 10-Q · filed 2021-05-13 | $4.63M derived: sum of 2 quarters · filed 2021-05-13 | $6.95M derived: sum of 3 quarters · filed 2021-05-13 | $9.23M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $2.33M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $4.65M derived: sum of 2 quarters · filed 2021-03-18 | $6.93M derived: sum of 3 quarters · filed 2021-03-18 | $9.20M 10-K · filed 2021-03-18 | ||||
| 2019-09-30 | $2.32M 10-Q · filed 2020-11-09 | $4.60M derived: sum of 2 quarters · filed 2020-11-09 | $6.87M 10-Q · filed 2020-11-09 | |||||
| 2019-06-30 | $2.28M 10-Q · filed 2020-08-14 | $4.55M 10-Q · filed 2020-08-14 |